Erasca Inc. Common Stock vs Texas Instruments Incorporated — how do they compare? Erasca Inc. Common Stock trades at $15.57 (market cap $4.95B), while Texas Instruments Incorporated trades at $291.62 (market cap $263.91B). The key difference: Texas Instruments Incorporated is far larger — about 53.3× Erasca Inc. Common Stock's market cap, and Texas Instruments Incorporated pays a 2.1% dividend while Erasca Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Erasca Inc. Common Stock for 0 Days and Texas Instruments Incorporated for 76 Days on average.
| ERAS | TXN | |
|---|---|---|
Market Cap | $4.95B | $263.91B |
Volume | 3,834,689 | 4,544,426 |
Sector | Health | Technology |
52-Week High | $22.47 | $332.35 |
52-Week Low | $2.20 | $153.33 |
Typical Hold Time | 0 Days | 76 Days |
Enterprise Value | $4.72B | $270.96B |
Dividend Yield | — | 2.1% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Texas Instruments (TXN) trades at $288.2, down 3.06% today amid a semiconductor sector sell-off. The stock shows strong technical momentum with bullish moving averages and key support at $286. Fundamentally, Q2 2026 EPS beat expectations at $2.14 versus $1.91, driven by data center sales doubling. Revenue growth is accelerating with 2026 projections at $19.5B, while maintaining robust profitability with 31.11% net margins. Recent dividend payments and institutional buying by CalSTRS signal confidence.
Outlook remains positive with 47.7% analyst buy ratings and $325 consensus price target offering 13% upside. Key catalysts include AI-driven data center expansion and industrial recovery. Risks include premium valuation (P/E 43.9) and cyclical semiconductor demand. The earnings recovery trajectory supports continued growth despite near-term volatility.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.
Read more on ERAS →Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.
Read more on TXN →